target directory

mln518 is an investigational drug targeting specific pathways involved in the pathophysiology of acute myelogenous leukemia aml clinical trial intelligence

Trials are included when the normalized target field matches this target directory. Full protocol, result, eligibility and IP analysis is available inside the premium workspace.